Dosing ERROR at AstraZeneca-Oxford University vaccine trial led to huge boost in jab’s success rate
Dosing ERROR by researchers in the AstraZeneca-Oxford University vaccine trial boosted its success rate to 90%, firm’s vice-president reveals AstraZeneca scientist Mene Pangalos says ‘serendipity,’ led to a break through ‘Mistake’ helped scientists discover half-dose was more effective than a full one More analysis needed to explain why an initial lower dose was more effective … Read more